Revive Therapeutics Signs MOU With Attwill Medical, Manufacturer For Vaxart, For Phase 3 Clinical Trials
Revive Therapeutics (CSE: RVV) (OTC: RVVTF) is one step closer to conducting its phase 3 clinical trials for the use
Read more
Vaxart
Revive Therapeutics Director Signs Manufacturing Arrangement With Vaxart
It appears that Revive Therapeutics (CSE: RVV) has a budding superstar on its board of directors. Last week, Revive’s independent
Read more